Step-down management of gastroesophageal reflux disease-Reference-Cited by-同舟云学术

Step-down management of gastroesophageal reflux disease

Published:2001-11 Issue:5 Volume:121 Page:1095-1100
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Inadomi John M.,Jamal Roula,Murata Glen H.,Hoffman Richard M.,Lavezo Laurence A.,Vigil Justina M.,Swanson Kathleen M.,Sonnenberg Amnon

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference26 articles.

1. Standard-dose lansoprazole is more effective than high-dose ranitidine in achieving endoscopic heal-ing and symptom relief in patients with moderately severe reflux oesophagitis;Jansen;Aliment Phar-macol Ther,1999

2. Treatment of erosive reflux esophagitis resistant to H2-receptor antagonist therapy. Lansoprazole, a new proton pump inhibitor;Robinson;Dig Dis Sci,1995

3. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H1/K(1)-ATPase inhibitor: a controlled, double-blind study;Feldman;Am J Gastroenterol,1993

4. Omeprazole or ranitidine in long-term treatment of reflux esophagitis;Hallerback;Gastroenterology,1994

5. Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety;Dent;Gut,1994

Cited by 163 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physicians’ perceptions and awareness of adverse effects of proton pump inhibitors and impact on prescribing patterns;Frontiers in Pharmacology;2024-06-26

2. Severe Anemia from Multiple Gastric Hyperplastic Polyps in a Hemodialysis Patient after Long-term Use of a Proton-pump Inhibitor;Internal Medicine;2024-03-01

3. Efficacy of a computer based discontinuation strategy to reduce PPI prescriptions: a multicenter cluster-randomized controlled trial;Scientific Reports;2023-12-07

4. Gastroesophageal Reflux Disease;Primary Care: Clinics in Office Practice;2023-09

5. A Pharmacogenetics-Based Approach to Managing Gastroesophageal Reflux Disease: Current Perspectives and Future Steps;Pharmacogenomics and Personalized Medicine;2023-06